戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ell line from a CHM patient harbouring a TAG nonsense mutation.
2 n which Slurp2 was inactivated with a simple nonsense mutation.
3 nd restoration of RP2 function for the R120X nonsense mutation.
4 ts suffering from genetic diseases caused by nonsense mutations.
5  the treatment of genetic diseases linked to nonsense mutations.
6 us laevis oocytes for eight missense and two nonsense mutations.
7 l protein production from genes disrupted by nonsense mutations.
8 at a broad range of genetic disorders due to nonsense mutations.
9 al type VII collagen in RDEB cells harboring nonsense mutations.
10   We compared molecular phenotypes of GABRG2 nonsense mutations.
11 tradermal gentamicin in 5 RDEB patients with nonsense mutations.
12  mutations in ADAMTSL4, including four novel nonsense mutations.
13 recisely model over 32,000 cancer-associated nonsense mutations.
14 y available treatment for RDEB patients with nonsense mutations.
15 es were nonsynonymous mutations and two were nonsense mutations.
16 ngths, complicating the process of detecting nonsense mutations.
17 vels are reduced in patients carrying ZBTB24 nonsense mutations.
18 ations, including 8 frameshift mutations, 10 nonsense mutations, 4 splice site mutations, 1 deletion,
19      Of these, 21 (2 frameshift mutations, 4 nonsense mutations, 4 splice site mutations, 1 deletion,
20  (19%): 29 missense mutations, 10 indels, 14 nonsense mutations, 9 frameshift mutations, and 5 splice
21 that the mutations carried by the patients-a nonsense mutation, a frameshift duplication, and five di
22                           R388 or a separate nonsense mutation act dominantly and are furthermore suf
23 tical phenotypes, we identified a homozygous nonsense mutation and a compound heterozygous mutation.
24 uals identified two cases harboring the same nonsense mutation and a further three unrelated individu
25                      In family 3, we found a nonsense mutation and a single-nucleotide duplication on
26 le-exome sequencing to identify a homozygous nonsense mutation and an in-frame multiexon deletion in
27 tivity in mdx mouse myotube cells carrying a nonsense mutation and induced significant amounts of dys
28                    NGS revealed 198 missense/nonsense mutations and 76 small indels in 76.4% of patie
29 ommon disease causing mutations in MECP2 are nonsense mutations and are responsible for over 35% of a
30 ct in the EPM2A gene, including missense and nonsense mutations and deletions.
31 ions and in-frame indels] versus truncating [nonsense mutations and frameshift indels]) and systemati
32 opical and intradermal gentamicin suppresses nonsense mutations and induces type VII collagen and AFs
33         RP2 patients frequently present with nonsense mutations and no treatments are currently avail
34 mmalian ribosome to suppress disease-causing nonsense mutations and partially restore the expression
35 mmalian ribosome to suppress disease-causing nonsense mutations and partially restore the expression
36  the treatment of genetic diseases caused by nonsense mutations and possessing low affinity toward mi
37 2 deleterious mutations (1 splice site and 1 nonsense mutation) and 1 missense mutation.
38 utation animal model of CHM harbouring a TAA nonsense mutation, and (2) a primary human fibroblast ce
39 lar variations (two single-base deletions, a nonsense mutation, and a canonical splice-site mutation)
40 included heterozygous splice site mutations, nonsense mutations, and a 1-bp insertion mutation, leadi
41                 Homozygous exonic deletions, nonsense mutations, and frameshift mutations in five fur
42 nonsynonymous mutations, MLL2 with different nonsense mutations, and PLCG1 with a recurrent nonsynony
43 cts harboring seven different PXE-associated nonsense mutations, and was evaluated by immunofluoresce
44 -414: (1) the chm(ru848) zebrafish, the only nonsense mutation animal model of CHM harbouring a TAA n
45 terations in SETD2, including frameshift and nonsense mutations, are present at 12% in a large de nov
46                   We identified 120 missense/nonsense mutations as well as 60 insertions/deletions af
47   MRI analysis of patients with missense and nonsense mutations as well as FOXC1-encompassing segment
48 M-deficient cells containing disease-causing nonsense mutations, as demonstrated by direct measuremen
49 truncated gamma2 subunits produced by GABRG2 nonsense mutations associated with epilepsy of different
50 four affected children were homozygous for a nonsense mutation at glutamate 210 (E210X) in the NEFL g
51 s of a series of mouse cell lines carrying a nonsense mutation at ND5 gene.
52      All 17 non-H2S-producing isolates had a nonsense mutation at position 1621 of phsA.
53              Sequencing of Irs1 identified a nonsense mutation at serine 57 (S57X), resulting in comp
54 that can induce PTC readthrough and suppress nonsense mutations at high concentrations.
55 as therapies for genetic disorders caused by nonsense mutations, because of their capacity to enhance
56 acerbate the phenotype of certain pathogenic nonsense mutations by preventing the expression of semi-
57    Cells can avoid the effects of so-called 'nonsense' mutations by several methods, including a newl
58 ples from hearing-impaired family members, a nonsense mutation c.3112C>T (p.Arg1038*) within adenylat
59 nconi anemia complementation gene M (FANCM), nonsense mutation c.5101C>T (p.Q1701X) was significantly
60  cups derived from a patient carrying an RP2 nonsense mutation c.519C > T (p.R120X), which lack detec
61 fibroblasts from an RP2 patient carrying the nonsense mutation c.519C>T (p.R120X) into induced plurip
62   Almost all NPPK patients carry the founder nonsense mutation c.796C>T (p.Arg266Ter) in the last exo
63     The maternal aunt was homozygous for the nonsense mutation (c.1017G>A [p.Trp339( *)]).
64 eletion (c.170_172delAGA [p.Lys57del]) and a nonsense mutation (c.1017G>A [p.Trp339( *)]).
65 date gene sequencing identified a homozygous nonsense mutation (c.1135G>T [p.Glu379X]) in ILDR1 as th
66   This sequencing revealed a homozygous GNB3 nonsense mutation (c.124C>T; p.Arg42Ter).
67 ariants in KIZ: one with the same homozygous nonsense mutation (c.226C>T [p.Arg76( *)]) and another w
68 d the fourth individual had a nearby de novo nonsense mutation (c.3070C>T [p.Arg1024 *]).
69                             The same de novo nonsense mutation (c.3385C>T [p.Arg1129 *]) was observed
70 hese subjects harbors a maternally inherited nonsense mutation (c.496C>T [p.Arg166*]) and a de novo s
71 ygosity on chromosome 6 and had a homozygous nonsense mutation (c.662C-->A, p.S221X) in NT5E, encodin
72 d a mutant zebrafish model with a homozygous nonsense mutation (c.706 C > T; p.Q236X) in exon 8 of ct
73                                          Two nonsense mutations (c.363C>A [p.Tyr121( *)] and c.1018C>
74 ied two different cosegregating heterozygous nonsense mutations (c.370C>T [p.Arg124*] and c.1066G>T [
75 ffected with RCD and identified a homozygous nonsense mutation, c.226C>T (p.Arg76( *)), in KIZ, which
76  individuals uncovered a second heterozygous nonsense mutation, c.2557C>T (p.Arg853( *)), in one simp
77           We report and characterize a novel nonsense mutation, c.3223delG (p.V1075Yfs*2), which lead
78 and exome sequencing identifies a homozygous nonsense mutation, c.496C>T (p.Arg166X), in a gene, KCNJ
79 tion, c.947delA (p.Lys316Serfs( *)90), and a nonsense mutation, c.850C>T (p.Arg284( *)), respectively
80 nesis imperfecta, we identified a homozygous nonsense mutation, c.884C-->A, p.Ser295*.
81                            Homozygous TWIST2 nonsense mutations, c.324C>T and c.486C>T, were identifi
82                                 Accordingly, nonsense mutations cause some of the most severe forms o
83                                     However, nonsense mutations caused membrane anchor loss in three
84                   Here, we identified a CmOr nonsense mutation (Cmor-lowbeta) that lowered fruit beta
85                       Eligible patients with nonsense-mutation cystic fibrosis (aged >/= 6 years; abn
86 e lung function in the overall population of nonsense-mutation cystic fibrosis patients who received
87 cacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis.
88  to neurofibromatosis type 1 based on an NF1 nonsense mutation detected in this patient.
89         One patient, heterozygous for a PKP2 nonsense mutation, developed severe heart failure and un
90                    Boys aged 7-16 years with nonsense mutation DMD and a baseline 6-minute walk dista
91 d safety of ataluren in ambulatory boys with nonsense mutation DMD.
92                             In contrast, the nonsense mutations E418X and R635X observed in 3 patient
93 king acylated anthocyanins, Vv3AT contains a nonsense mutation encoding a truncated protein that lack
94 dentified a new causative gene, GNAL, with a nonsense mutation encoding p.Ser293* resulting in a prem
95 e numbers of genetic disorders are caused by nonsense mutations for which compound-induced readthroug
96      There were zero false-positive calls of nonsense mutations, frameshift mutations, or genomic rea
97                       Null alleles with ACC2 nonsense mutations, frameshift mutations, small deletion
98 X) of the PRKAR1A gene, several missense and nonsense mutations have been observed recently in acrody
99                           Similarly, a Dyrk2 nonsense mutation identified in breast cancer compromise
100                       Strikingly, the Rbfox2 nonsense mutation identified in HLHS patients truncates
101 ncated variants resulting from low-frequency nonsense mutations identified in humans.
102 g two 2-bp-deletion mutations, the first non-nonsense mutations identified.
103 encing, we identified a de novo heterozygous nonsense mutation in a gene encoding thyroid hormone rec
104                  We identified a spontaneous nonsense mutation in a known Esx-1-associated gene which
105                  The remaining variant was a nonsense mutation in a predicted gene, C9orf75, renamed
106 re heterozygous variants, including an early nonsense mutation in a proband with femorogluteal lipody
107 rst ADAMTSL4 mouse model, tvrm267, bearing a nonsense mutation in Adamtsl4.
108 uent next-generation sequencing identified a nonsense mutation in AGBL1 in the 15q locus; this mutati
109 novel neurofilament light polypeptide (NEFL) nonsense mutation in all affected members.
110 , we traced tail loss in human marapsin to a nonsense mutation in an ancestral ape, compared substrat
111                  The recently described CDSN nonsense mutation in another PSS family also resulted in
112  adaptor protein complex 4 (AP4) subunits: a nonsense mutation in AP4S1 (NM_007077.3: c.124C>T, p.Arg
113 d not have a family history of CRC carried a nonsense mutation in APC (p.Arg216X).
114 ence that one of the identified mutations, a nonsense mutation in bmp1a, underlies the welded mutant
115       We established a zebrafish line with a nonsense mutation in brca2 exon 11 (brca2(Q658X)), a mut
116 mycin as was a DeltabrlR mutant because of a nonsense mutation in brlR.
117    Sequence analysis identified a homozygous nonsense mutation in CEP19, the gene encoding the ciliar
118 nges in DCLRE1C and IL7R; and a heterozygous nonsense mutation in CHD7.
119 nin T (ssTnT encoded by TNNT1 gene) due to a nonsense mutation in codon Glu(180) causes a lethal form
120 JH1 interval and subsequent SNP validation a nonsense mutation in CWC15 was identified as the likely
121  in sapje, a zebrafish line with a recessive nonsense mutation in dystrophin.
122 nse mutation in combination with a recurrent nonsense mutation in ENPP1 was discovered in a pediatric
123                                            A nonsense mutation in ERCC5 discovered in both the primar
124                 We identified a heterozygous nonsense mutation in exon 1 of CTLA4.
125 exome sequencing, we identified a homozygous nonsense mutation in exon 2 of FAM20A that was not prese
126 ckout mice (Slurp1X(-/-) mice) with a simple nonsense mutation in exon 2.
127 is LMS (McLMS) is weakly expressed and has a nonsense mutation in exon 3.
128 mically induced mutant, nmf192, that bears a nonsense mutation in exon 4 of Nphp4.
129  epidermolysis bullosa revealed a homozygous nonsense mutation in exon 6 of EXPH5: c.3917C>G, p.Ser13
130         Herein, we report a novel homozygous nonsense mutation in EXPH5 responsible for an EBS subtyp
131 morphisms in HBGA genes, and in particular a nonsense mutation in FUT2 (G428A), result in resistance
132   All patients contained the same homozygous nonsense mutation in IKBKB (R286X), revealed by whole-ex
133 drome, a lethal disorder that results from a nonsense mutation in IKKA, revealed an absence of peride
134 aled mutations in FMN2, NEB, and SYNE1 and a nonsense mutation in KMT2D, all shared by the FL and B-L
135                               In contrast, a nonsense mutation in MEI-1 caused assembly of meiotic sp
136 y, we identified the c.472C>T (p.Arg158( *)) nonsense mutation in MFAP5 encoding the extracellular ma
137 tation of Syb1 resulting from a spontaneous, nonsense mutation in mice significantly impairs the func
138               Homozygous knockin mice with a nonsense mutation in Mypn showed Z-streaming and nemalin
139 hromosomal variants, we identified a de novo nonsense mutation in NDUFB11 (Xp11.23) in one female ind
140  Sse(A+) SpeB(A+) isolate identified a C605A nonsense mutation in orphan kinase gene rocA, and 6 othe
141                           We have reported a nonsense mutation in PIK3R1, which encodes the regulator
142                 This identified a homozygous nonsense mutation in PLDN in a boy with characteristic f
143                          A rare heterozygous nonsense mutation in PNKD was co-segregated with TD in t
144 ine-dependent epilepsy revealed a homozygous nonsense mutation in proline synthetase co-transcribed h
145       One patient was homozygous for a novel nonsense mutation in PSMB8 (c.405C>A), suggesting a prot
146                               In addition, a nonsense mutation in RPS6KA3 was found in one patient in
147                                            A nonsense mutation in SLC16A12 (c.643C>T; p.Q215X) causes
148                      A germline heterozygous nonsense mutation in SUFU was identified in one of four
149 gh-persistence phenotype was attributed to a nonsense mutation in the 3' end of the shpB gene encodin
150 60 cells, which we show contain a hemizygous nonsense mutation in the Arkadia/RNF111 gene, efficientl
151 amilies, we identified a homozygous germline nonsense mutation in the base-excision repair (BER) gene
152 82 and TX6051 and found a single mutation, a nonsense mutation in the ccpA gene of TX6051.
153 ional studies based on a patient harboring a nonsense mutation in the common part of the MASP1 gene a
154 ed skin fragility disorder with a homozygous nonsense mutation in the dystonin gene (DST) that encode
155 perties were shown to be due to a homozygous nonsense mutation in the EFG1 gene.
156 whole exome sequencing revealed a homozygous nonsense mutation in the ERCC6L2 gene.
157                                          The nonsense mutation in the FAM136A gene leads to a stop co
158 e Treg cell deficiency was found to harbor a nonsense mutation in the gene encoding LPS-responsive be
159                                We detected a nonsense mutation in the gene encoding the transcription
160  OA in osteoclastogenesis, using mice with a nonsense mutation in the Gpnmb gene (D2J) and wild-type
161 th epilepsy of different severities and by a nonsense mutation in the last exon unassociated with epi
162 ified an outbreak lineage characterized by a nonsense mutation in the mismatch repair component MSH2.
163 zygous frameshift mutations and a homozygous nonsense mutation in the mitogen-activated protein tripl
164   Here we report a patient with a homozygous nonsense mutation in the MKL1 gene resulting in immunode
165       We have previously demonstrated that a nonsense mutation in the NPC2 gene, which encodes ubiqui
166 differ by a single base pair, which causes a nonsense mutation in the putative methyltransferase gene
167 we describe a new zebrafish model carrying a nonsense mutation in the rpgrip1 gene.
168 educed sensitivity to ethylene and carries a nonsense mutation in the single pea (Pisum sativum) orth
169 es within this region, we found a homozygous nonsense mutation in the SPATA7 gene in Saudi Arabian fa
170 by a pineal complex phenotype, and carries a nonsense mutation in the T-box domain of the tbx2b trans
171                          Affected mice had a nonsense mutation in the thyroid hormone receptor intera
172 that suppression is highly correlated with a nonsense mutation in the US9 gene, which plays a critica
173 eatment and drug-resistant tumors revealed a nonsense mutation in TSC2, a negative regulator of mTOR,
174 ants, while the remaining mutant contained a nonsense mutation in uhpA The expression of uhpT was abs
175                   We previously identified a nonsense mutation in Vaccinia-related kinase 1 (VRK1), R
176 us, our results suggest that read-through of nonsense mutations in ABCC6 by PTC124 may have potential
177 ome of the most sensitive accessions contain nonsense mutations in ACC2, including the "Nossen" line
178                           Twelve missense or nonsense mutations in AIRE and two chimeric AIRE constru
179 uence variants revealed homozygosity for two nonsense mutations in ALDH1A3, c.568A>G, predicting p.Ly
180 were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin
181 ion of suppressor tRNAs or identification of nonsense mutations in any of the archaeal genes.
182 ed from skin biopsies of patients harbouring nonsense mutations in AP5Z1 and presenting with spastic
183                    We report that homozygous nonsense mutations in APP are associated with decreased
184                                 Strains with nonsense mutations in chlamydial cytotoxins, guaBA-add,
185           Since over 30% of patients harbour nonsense mutations in CHM, nonsense suppression therapy
186                                              Nonsense mutations in CLN1 account for 52.3% of all dise
187  the recessive UCMD cases have frameshift or nonsense mutations in COL6A1, COL6A2, or COL6A3, recessi
188 s may parallel the role of CREBBP frameshift/nonsense mutations in DLBCL that result in loss of the p
189 ping is capable of correcting frameshift and nonsense mutations in Duchenne muscular dystrophy.
190                                Patients with nonsense mutations in dystrophin are specifically target
191                   We identified heterozygous nonsense mutations in four and potentially disease-causi
192                     Here we focused on three nonsense mutations in GABRG2 (GABRG2(R136*), GABRG2(Q390
193 are frequently associated with epilepsy, and nonsense mutations in GABRG2 are associated with several
194                                              Nonsense mutations in genes that are involved in histone
195            In addition, we identified FAM83H nonsense mutations in Hispanic (C1330C>T; p.Q444X) and C
196 rt a syndrome caused by de novo heterozygous nonsense mutations in KAT6A (a.k.a., MOZ, MYST3) identif
197  leads to increased frequencies of recurrent nonsense mutations in key tumor suppressors such as TP53
198 ecules that induce ribosomal read-through of nonsense mutations in mRNA and allow production of a ful
199 isease due to heterozygosity for missense or nonsense mutations in MYH3, which encodes embryonic myos
200                                              Nonsense mutations in Nav.1.7, the main pain signaling v
201               Eight missense mutations and 3 nonsense mutations in NBCe1-A cause severe proximal rena
202 helial cells (ECs) to show that heterozygous nonsense mutations in NOTCH1 that cause aortic valve cal
203                       In 2 subjects,we found nonsense mutations in RNF43, indicating that it is also
204 al therapeutic functions in the treatment of nonsense mutations in the ATM and the dystrophin genes.
205 ation, frameshift, missense, splice-site and nonsense mutations in the Chordin-like 1 gene (CHRDL1) o
206 ically caused by frame-shifting deletions or nonsense mutations in the gene encoding dystrophin and c
207 n a subset of patients, this is explained by nonsense mutations in the gene encoding filaggrin (FLG).
208  are homozygous or compound heterozygous for nonsense mutations in the gene that encodes the cytoskel
209                                              Nonsense mutations in the last exon do not activate NMD,
210  cell (hiPSC)-derived cardiomyocytes bearing nonsense mutations in the sodium channel gene SCN5A, whi
211  p53) mutations, in cells from patients with nonsense mutations in the TPP1 (tripeptidyl peptidase 1)
212 orted two unrelated families with homozygous nonsense mutations in this DST isoform that led to ultra
213 we sequenced and identified likely causative nonsense mutations in two and candidate mutations in the
214 mined, revealing four independently acquired nonsense mutations in two other ApiAP2 genes, and five i
215 tly found compound heterozygous missense and nonsense mutations in WDR35 in an independent second cas
216 wo homozygous mutations, a splice-site and a nonsense mutation, in two consanguineous families of Bed
217 ived from the individuals with TD due to the nonsense mutation, indicating nonsense-mediated mRNA dec
218 -targeting system by introducing an in-frame nonsense mutation into the coding sequence of Cre recomb
219             Disease severity associated with nonsense mutations is dependent partially on mutation ge
220       A strategy to overcome disease-causing nonsense mutations is treatment with nonsense mutation s
221 variation of ARHGAP29 translates to an early nonsense mutation (K326X), presumably resulting in loss-
222                    The seventh patient had a nonsense mutation leading to a premature stop codon muta
223     NOTCH aberrations include frameshift and nonsense mutations leading to receptor truncations as we
224                                          The nonsense mutation leads to an early truncation of the G
225                                          The nonsense mutation leads to very low levels of HSD17B4 tr
226 amily, Sanger sequencing of MASP1 revealed a nonsense mutation, MASP1 c.870G>A (p.W290X), that also c
227               From the genome data, the rare nonsense mutations may not contribute to fecundity, wher
228                                         This nonsense mutation model recapitulates the molecular, his
229  currently used mouse model, twitcher, has a nonsense mutation not found in Krabbe patients, although
230 have shown that mice homozygous for the Aspa nonsense mutation Nur7 also develop brain vacuolation.
231 ct, we found a common haplotype on which the nonsense mutation occurred and that segregates in the As
232 es revealed a truncated variant with a G216* nonsense mutation of the 408-amino-acid TC0668 protein t
233 ysis revealed a single pathogenic homozygous nonsense mutation of the caspase recruitment domain 11 (
234                Positional cloning revealed a nonsense mutation of tln1 in this mutant.
235                       NGS identified somatic nonsense mutations of AT-rich interactive domain 1A (SWI
236                We assessed the effect of the nonsense mutation on mRNA levels and evaluated the NMJ t
237 entifies previously unidentified missense or nonsense mutations on both alleles in all affected subje
238 d 6 other Sse(A+) SpeB(A+) isolates also had nonsense mutations or small indels in rocA RocA and CovS
239                              We introduced a nonsense mutation originally identified in a child with
240 PK4 that resulted in the introduction of the nonsense mutation p.Ser376X into the encoded ankyrin rep
241 ted for an association between the c.5791C>T nonsense mutation (p.Arg1931*; rs144567652) in exon 22 o
242 ition mutation (c.55T>C), which results in a nonsense mutation (p.Arg19X) in alternatively spliced ex
243                 We subsequently identified a nonsense mutation (p.E245X) in SERPINB6, which is locate
244 exome sequencing (WES) revealed a homozygous nonsense mutation (p.R1105X) of the AP4E1 gene, which wa
245 ized a new mouse model containing a knock-in nonsense mutation (p.R255X) in the Mecp2 locus (Mecp2(R2
246 ere found in C2ORF71 in human RP patients: A nonsense mutation (p.W253X) in the first exon is likely
247 284S, p.R288S, p.G301R, p.P425S), three were nonsense mutations (p.Q51X, p.Y149X, p.C156X), three wer
248 es led to the identification of 3 homozygous nonsense mutations (p.R181X, p.S297X, and p.Q414X) in SL
249 ally diagnosed with OTCS, revealed a de novo nonsense mutation, p.Q638*, in the MAGEL2 gene.
250 ed that in case of the most common recurrent nonsense mutation, p.R1141X, the read-through may result
251                       We describe homozygous nonsense mutation, p.S24X, and homozygous splice site mu
252      In family 2, we identified a homozygous nonsense mutation predicted to produce truncated WNT1.
253                          The location of the nonsense mutations predicts escape of mutant ZIC1 transc
254 in of 11 rationally selected factor IX (FIX) nonsense mutations, present in 70% (324/469) of hemophil
255                               In addition to nonsense mutations, proinflammatory cytokines and some d
256                     One gene, ABCG5, had two nonsense mutations (Q16X and R446X).
257          The GABA(A) receptor gamma2 subunit nonsense mutation Q351X has been associated with the gen
258 lt, three were loss-of-function mutations: a nonsense mutation (R19X) and two splice-site mutations (
259                   These consisted of a novel nonsense mutation R39X; a missense mutation, R47L in two
260 G); this splicing mutation compounded with a nonsense mutation (R523>X) and abolished SCN9A mRNA expr
261  to knock-down gene expression and drugs for nonsense mutation read-through.
262                  Here, we expressed multiple nonsense mutation reporters in human cells and yeast and
263                          Although all GABRG2 nonsense mutations resulted in loss of gamma2 subunit su
264 e positively selected SNPs, four represented nonsense mutations resulting in stop codons, three of th
265                As in other vertebrates, this nonsense mutation results in eyeless animals, and is let
266 0(-7) and p = 1.5x10(-6) respectively) and a nonsense mutation rs3211938 within CD36 is associated wi
267             Homozygotes (A/A) for the common nonsense mutation rs601338A>G (W143X) are nonsecretors a
268  three are splicing site mutations, four are nonsense mutations, seven are missense mutations, two ar
269  by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivit
270 o inactivate the gene product as a result of nonsense mutations, splice site mutation, or out-of-fram
271  Mecp2(R255X) embryonic fibroblasts with the nonsense mutation suppressing drug gentamicin and we wer
272 causing nonsense mutations is treatment with nonsense mutation suppressing drugs that allow expressio
273 f Pax6 dosage through a mutation-independent nonsense mutation suppression strategy would limit progr
274 ct indicated that a CD36 haplotype bearing a nonsense mutation (T1264G; rs3211938) had undergone rece
275                                 A homozygous nonsense mutation (Ter) in murine Dnd1 (Dnd1(Ter/Ter)) r
276 eighth amino acid of the GnRH decapeptide, 1 nonsense mutation that causes premature termination with
277 n in the catalytic domain and the other is a nonsense mutation that eliminates the catalytic domain.
278  analysis of NRT1.1 in the mutant revealed a nonsense mutation that truncated the NRT1.1 protein at a
279                           These include five nonsense mutations that generate C-terminal truncations
280  error prone, often generating frameshift or nonsense mutations that render the rearranged TCR and Ig
281       Development of aniridia is linked with nonsense mutations that result in paired box 6 (PAX6) ha
282  proteins, we focused on variations that are nonsense mutations that ultimately resulted in a gain of
283  it is being actively pursued as a potential nonsense mutation therapy.
284  and rapidly degrades transcripts harbouring nonsense mutations to limit accumulation of non-function
285                                              Nonsense mutations underlie about 10% of rare genetic di
286                                 A homozygous nonsense mutation was identified in exon 1 of the TYR ge
287 y of this drug to facilitate read-through of nonsense mutations was examined in HEK293 cells transfec
288 g sequences, removal of sequences containing nonsense mutations was found to be a valuable filter in
289    The inhibitor risk in large deletions and nonsense mutations was higher than in intron 22 inversio
290 y test the ability of PTC124 to read through nonsense mutations, we conducted a detailed assessment c
291 sruption of protein function: frameshift and nonsense mutations were classified as "null," whereas mi
292                                         SPEN nonsense mutations were detectable in the ERalpha-expres
293  or drugs developed to allow read-through of nonsense mutations, whereas other therapies deal with se
294                               There are also nonsense mutations, which act as the equivalent of a nul
295 in production in genetic disorders caused by nonsense mutations, which are the cause of cystic fibros
296 r with cystic fibrosis and at least one CFTR nonsense mutation, who were enrolled in the trial betwee
297 se of gentamicin to suppress disease-causing nonsense mutations will require their long term administ
298 ering from multiple genetic disorders due to nonsense mutations with a single small-molecule drug tha
299 ransgene were mutagenized to create a single nonsense mutation within the open reading frame of each
300 scular dystrophy patient myotubes carrying a nonsense mutation within the SYNE1 gene (23560 G>T) enco

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top